Carcinogenesis, Vol. 21, No. 3, 353-359,
March 2000
© 2000 Oxford University Press
Carcinogenesis |
Carcinogen macromolecular adducts and their measurement
Carcinogen–DNA Interactions Section, LCCTP, Division of Basic Sciences, NCI, NIH, Building 37, Room 2A05, 37 Convent Drive, MSC-4255, Bethesda, MD 20892,
1 Joseph L.Mailman School of Public Health of Columbia University, 701 West 168th Street, New York, NY 10032,
2 Molecular Carcinogenesis Team, TMBB, Health Effects Laboratory Division, NIOSH, CDC, 1095 Willowdale Road, Morgantown, WV 26505, USA
Damage to DNA induced by carcinogenic chemicals reflects exposure and is directly related to tumor formation, whereas modification of protein provides relatively precise dosimetry for stable adducts of proteins with a known half-life. Sophisticated methods for the detection and quantitation of DNA and protein adducts have been developed during the last ~25 years. For DNA adducts the most widely used methods include electrochemical detection, mass spectrometry, fluorescence and phosphorescence spectroscopy, immunoassays and immunohistochemistry and 32P-post-labeling. Detection limits for quantitative assays are typically in the range of 1 adduct in 107 or 109 nucleotides. However, accelerator mass spectrometry, which is highly sophisticated but less accessible, has a detection limit of ~1 adduct in 1012 nucleotides. Methods for the determination of protein adducts include immunoassay and a variety of elegant high-resolution mass spectrometry approaches. The detection limit of ~0.1 fmol for protein adducts, is based primarily on method specificity and the availability of large quantities of sample material. Using these highly sensitive methods a major achievement has been the biomonitoring of chemically exposed human populations. Validation of macromolecular adduct formation in humans has been predicated on studies in animal models. Adduct formation in humans appears to be indicative of molecular dosimetry and suggestive of increased human cancer risk. However, despite the large body of literature documenting DNA and protein adduct molecular dosimetry for many carcinogen exposures, the relationship between adduct formation and human cancer risk has been defined for only a few carcinogens. Thus, elucidation of this association remains a compelling challenge. For the future, integration of DNA and protein adduct measurements together with documentation of correlative and subsequent events, and host susceptibility factors, within the context of valid molecular epidemiologic study designs, will further our understanding of human disease mechanisms.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. E. Coldwell, S. M. Cutts, T. J. Ognibene, P. T. Henderson, and D. R. Phillips Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations Nucleic Acids Res., September 1, 2008; 36(16): e100 - e100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gyorffy, L. Anna, K. Kovacs, P. Rudnai, and B. Schoket Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts Mutagenesis, January 1, 2008; 23(1): 1 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Pesch, M. Kappler, K. Straif, B. Marczynski, R. Preuss, B. Rossbach, H.-P. Rihs, T. Weiss, S. Rabstein, C. Pierl, et al. Dose-Response Modeling of Occupational Exposure to Polycyclic Aromatic Hydrocarbons with Biomarkers of Exposure and Effect Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1863 - 1873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ben-Zaken Cohen, P. D. Pare, S. F. P. Man, and D. D. Sin The Growing Burden of Chronic Obstructive Pulmonary Disease and Lung Cancer in Women: Examining Sex Differences in Cigarette Smoke Metabolism Am. J. Respir. Crit. Care Med., July 15, 2007; 176(2): 113 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Dong, N. Suzuki, M. C. Torres, R. R. Bonala, F. Johnson, A. P. Grollman, and S. Shibutani QUANTITATIVE DETERMINATION OF ARISTOLOCHIC ACID-DERIVED DNA ADDUCTS IN RATS USING 32P-POSTLABELING/POLYACRYLAMIDE GEL ELECTROPHORESIS ANALYSIS Drug Metab. Dispos., July 1, 2006; 34(7): 1122 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Hecht DNA Adducts of Tobacco Smoke Carcinogens Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 217 - 222. [Full Text] [PDF]
|
|
|
|
|
|
V. M. Arlt 3-Nitrobenzanthrone, a potential human cancer hazard in diesel exhaust and urban air pollution: a review of the evidence Mutagenesis, November 1, 2005; 20(6): 399 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Sharma and P. B. Farmer Biological Relevance of Adduct Detection to the Chemoprevention of Cancer Clin. Cancer Res., August 1, 2004; 10(15): 4901 - 4912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gyorffy, L. Anna, Z. Gyori, J. Segesdi, J. Minarovits, I. Soltesz, S. Kostic, A. Csekeo, M. C. Poirier, and B. Schoket DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay Carcinogenesis, July 1, 2004; 25(7): 1201 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, M. Chen, H. Yagi, D. M. Jerina, and S. G. Carmella r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in Human Urine: A Potential Biomarker for Assessing Polycyclic Aromatic Hydrocarbon Metabolic Activation Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1501 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Bacon, G. Williamson, R. C. Garner, G. Lappin, S. Langouet, and Y. Bao Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepatocytes Carcinogenesis, December 1, 2003; 24(12): 1903 - 1911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tsuda, S. Fukushima, H. Wanibuchi, K. Morimura, D. Nakae, K. Imaida, M. Tatematsu, M. Hirose, K. Wakabayashi, and M. A. Moore Value of GST-P Positive Preneoplastic Hepatic Foci in Dose-Response Studies of Hepatocarcinogenesis: Evidence for Practical Thresholds with Both Genotoxic and Nongenotoxic Carcinogens. A Review of Recent Work Toxicol Pathol, January 1, 2003; 31(1): 80 - 86. [Abstract] [PDF]
|
|
|
|
|
|
D. H. Phillips Smoking-related DNA and protein adducts in human tissues Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Divi, F. A. Beland, P. P. Fu, L. S. Von Tungeln, B. Schoket, J. E. Camara, M. Ghei, N. Rothman, R. Sinha, and M. C. Poirier Highly sensitive chemiluminescence immunoassay for benzo[a]pyrene-DNA adducts: validation by comparison with other methods, and use in human biomonitoring Carcinogenesis, December 1, 2002; 23(12): 2043 - 2049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. P. Perera, L. A. Mooney, M. Stampfer, D. H. Phillips, D. A. Bell, A. Rundle, S. Cho, W.-Y. Tsai, J. Ma, A. Blackwood, et al. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study Carcinogenesis, October 1, 2002; 23(10): 1641 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Gammon, R. M. Santella, A. I. Neugut, S. M. Eng, S. L. Teitelbaum, A. Paykin, B. Levin, M. B. Terry, T. L. Young, L. W. Wang, et al. Environmental Toxins and Breast Cancer on Long Island. I. Polycyclic Aromatic Hydrocarbon DNA Adducts Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zhao and K. Hemminki The in vivo levels of DNA alkylation products in human lymphocytes are not age dependent: an assay of 7-methyl- and 7-(2-hydroxyethyl)-guanine DNA adducts Carcinogenesis, February 1, 2002; 23(2): 307 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tang, D. H. Phillips, M. Stampfer, L. A. Mooney, Y. Hsu, S. Cho, W.-Y. Tsai, J. Ma, K. J. Cole, M. N. She, et al. Association between Carcinogen-DNA Adducts in White Blood Cells and Lung Cancer Risk in the Physicians Health Study Cancer Res., September 1, 2001; 61(18): 6708 - 6712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. P. Guengerich Metabolism of chemical carcinogens Carcinogenesis, March 1, 2000; 21(3): 345 - 351. [Abstract] [Full Text] [PDF]
|
|